HeraMED Ltd. (DE:1I4)
FRANKFURT:1I4
Holding DE:1I4?
Track your performance easily

HeraMED Ltd. (1I4) Financial Statements

0 Followers

HeraMED Ltd. Financial Overview

HeraMED Ltd.'s market cap is currently ―. The company's EPS TTM is €-0.012; its P/E ratio is -0.85; HeraMED Ltd. is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Dec 21Dec 20
Income Statement-
Total Revenue---
Gross Profit---
EBIT---
EBITDA---
Net Income Common Stockholders---
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments-€ 3.56M€ 2.48M
Total Assets-€ 4.59M€ 4.15M
Total Debt€ 0.00€ 3.42M€ 249.26K
Net Debt€ 0.00€ -140.91K€ -2.23M
Total Liabilities-€ 4.70M€ 1.56M
Stockholders Equity-€ -105.98K€ 2.60M
Cash Flow-
Free Cash Flow---
Operating Cash Flow---
Investing Cash Flow---
Financing Cash Flow---
Currency in EUR

HeraMED Ltd. Earnings and Revenue History

HeraMED Ltd. Debt to Assets

HeraMED Ltd. Cash Flow

HeraMED Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis